Himanshu Muktilal Zota has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Himanshu Muktilal Zota, Promoter and Whole-time Director of Zota Health Care Limited, has filed an annual disclosure under SEBI Takeover Regulations for the year ended March 31, 2025. In the filing, he declares that no promoter or person acting in concert has created any new encumbrance (such as pledge or lien) on the company's shares during FY 2024-25, beyond what was already disclosed earlier. The filing includes a list of all 39 promoter and promoter group entities, including individuals and HUFs. This is a routine annual compliance submission required from promoters each year.
This is a routine compliance filing with no new encumbrance or change in promoter holdings. Investors can take comfort that there has been no new pledging or unlocking of shares by promoters during the year, indicating stability in promoter shareholding.